SOX2 and breast carcinoma: Inducibly elevating SOX2 (~5 to 7-fold) in glioblastoma (U87, U118), medulloblastoma (DAOY), breast carcinoma (MDA-MB-231), and prostate carcinoma (DU145) cell lines led to growth inhibition in each case.